BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $468 | -99.9% | 9,180 | -1.1% | 0.17% | -11.2% |
| Q3 2022 | $500,000 | -28.8% | 9,280 | -15.1% | 0.19% | -18.3% |
| Q2 2022 | $702,000 | -15.9% | 10,931 | +1.6% | 0.23% | +0.4% |
| Q1 2022 | $835,000 | -9.8% | 10,763 | -0.2% | 0.23% | -5.4% |
| Q4 2021 | $926,000 | +5.6% | 10,788 | -1.0% | 0.24% | -4.0% |
| Q3 2021 | $877,000 | -0.7% | 10,898 | -0.6% | 0.25% | 0.0% |
| Q2 2021 | $883,000 | -3.6% | 10,969 | +1.0% | 0.25% | -10.7% |
| Q1 2021 | $916,000 | +6.0% | 10,864 | +0.9% | 0.28% | -4.7% |
| Q4 2020 | $864,000 | -2.6% | 10,764 | -2.4% | 0.30% | -12.5% |
| Q3 2020 | $887,000 | -5.5% | 11,028 | +1.2% | 0.34% | -14.0% |
| Q2 2020 | $939,000 | +6.3% | 10,901 | +0.2% | 0.39% | -13.5% |
| Q1 2020 | $883,000 | -4.1% | 10,875 | -1.3% | 0.45% | +25.1% |
| Q4 2019 | $921,000 | -5.4% | 11,014 | -1.1% | 0.36% | -11.7% |
| Q3 2019 | $974,000 | +5.8% | 11,134 | -1.0% | 0.41% | +6.8% |
| Q2 2019 | $921,000 | +1.0% | 11,251 | +0.3% | 0.38% | -0.5% |
| Q1 2019 | $912,000 | +23.6% | 11,216 | 0.0% | 0.39% | +11.6% |
| Q4 2018 | $738,000 | -15.8% | 11,216 | -1.4% | 0.35% | +1.2% |
| Q3 2018 | $877,000 | +2.0% | 11,381 | -2.2% | 0.34% | -5.3% |
| Q2 2018 | $860,000 | +9.7% | 11,641 | -3.4% | 0.36% | +8.1% |
| Q1 2018 | $784,000 | -0.4% | 12,056 | -0.9% | 0.33% | +4.7% |
| Q4 2017 | $787,000 | 0.0% | 12,170 | -2.9% | 0.32% | -5.3% |
| Q3 2017 | $787,000 | +3.0% | 12,536 | -0.7% | 0.34% | -0.6% |
| Q2 2017 | $764,000 | +15.2% | 12,622 | -1.3% | 0.34% | +13.4% |
| Q1 2017 | $663,000 | +17.3% | 12,786 | +0.3% | 0.30% | +12.8% |
| Q4 2016 | $565,000 | -6.5% | 12,746 | +0.4% | 0.26% | -10.5% |
| Q3 2016 | $604,000 | +2.2% | 12,696 | -2.8% | 0.30% | 0.0% |
| Q2 2016 | $591,000 | -6.8% | 13,068 | -15.4% | 0.30% | -9.8% |
| Q1 2016 | $634,000 | -1.4% | 15,442 | -8.3% | 0.33% | 0.0% |
| Q4 2015 | $643,000 | +17.3% | 16,842 | +1.0% | 0.33% | +10.8% |
| Q3 2015 | $548,000 | -53.0% | 16,667 | 0.0% | 0.30% | -48.1% |
| Q2 2015 | $1,166,000 | +2.1% | 16,667 | 0.0% | 0.57% | +2.9% |
| Q1 2015 | $1,142,000 | -5.8% | 16,667 | +0.8% | 0.55% | -7.5% |
| Q4 2014 | $1,212,000 | +2.1% | 16,542 | 0.0% | 0.60% | -2.1% |
| Q3 2014 | $1,187,000 | -0.8% | 16,542 | 0.0% | 0.61% | +2.0% |
| Q2 2014 | $1,196,000 | -0.4% | 16,542 | +1.3% | 0.60% | -4.0% |
| Q1 2014 | $1,201,000 | +4.3% | 16,327 | -1.3% | 0.62% | +5.4% |
| Q4 2013 | $1,151,000 | – | 16,550 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |